Last reviewed · How we verify

NCT05483556

tDCS Effects on Brain Plasticity in Aphasia Treatment

Status unknown NA Last updated 18 January 2024
What this trial tests

NA trial testing Real tDCS in Aphasia in 10 participants. Status unknown.

Timeline
1 November 2021
Primary endpoint
31 October 2024
31 October 2024

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment10
Start date1 November 2021
Primary completion31 October 2024
Estimated completion31 October 2024
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 18 to 65, any sex, with Aphasia or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The efficacy of conventional speech therapy alone for aphasia recovery is inconclusive. The prospective study will monitor the effects of combined language therapy and tDCS through structural and functional MRI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Real tDCS

Trials testing the same drug.

Other recruiting trials for Aphasia

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing